However, some mild side effects may occur, especially during the adjustment period or at higher doses: Headaches Temporary injection site irritation Lightheadedness Water retention (in rare cases) Mild tingling or numbness (from elevated IGF-1) Ipamorelin induced growth hormone release without elevating cortisol or ACTH levels, suggesting minimal off-target effects. Raun et al., European Journal of Endocrinology Compared to Other Peptides Unlike GHRP6 , which often causes intense hunger and spikes in prolactin , or GHRP2 , which can increase cortisol , Ipamorelin is more targeted and stable
BioPeptides provides high-purity peptides with verified CAS documentation and laboratory-grade packaging.
Enhancement of satiety signaling through multiple hormone pathways
Research design questions about combining compounds across mechanisms are outside the scope of supplier guidance
These are almost always mild, temporary, and dose-dependent
CJC-1295 and Tesamorelin both relate to growth hormone-releasing pathways, but they are not the same
